Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

This study aims to evaluate the efficacy and safety of picankibart for the treatment of moderately to severely active ulcerative colitis (modified Mayo score of 4 to 9 with an endoscopic subscore of ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Claims about food and immunity are everywhere. Now scientists are exploring exactly how nutrition acts on the immune system ...

Severe malnutrition is treated with ready-to-use therapeutic food, a paste combining peanuts, sugar, milk powder, oil, ...

More than half of independent pharmacies are considering not stocking the first 10 drugs that were subject to Medicare price ...

FibroB (Nasdaq: FBLG) (“FibroBiologics , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic ...

Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on ...

If you’ve ever had a professional facial, you know the sensation of having your face enveloped in a cloud of steam—a soft, ...

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...